Managing Dermatologic AEs With Amivantamab/Lazertinib: Updates From the COCOON Clinical Trial
Panelists discuss how the COCOON study’s advanced dermatologic prophylaxis protocol, including systemic antibiotics and topical treatments, can reduce skin toxicities by 50% in patients receiving amivantamab plus lazertinib therapy.